Today in business: 5 things you need to know

New York plans to sue Wells Fargo and Bank of America, Neiman Marcus preps for a possible IPO, and more

Neiman Marcus owners may ask for around $8 billion in a possible IPO.
(Image credit: JOHN GRESS/Reuters/Corbis)

1. PHARMACEUTICAL COMPANIES HUNT FOR LESS ADDICTIVE PAINKILLERS

After the FDA moved last month to block the manufacture and sale of generic OxyContin, pharmaceutical companies are competing to produce and patent a painkiller that's more difficult to abuse. A new formulation of OxyContin now includes an ingredient that makes it harder to crush for snorting, and another drug, Opana, contains an ingredient that turns into a jelly-like substance when heated up for injection. One biotech firm is experimenting with a plastic injection molding — the same kind used in Legos — that makes the pill so hard that it chips the blades of a coffee grinder. A recent Cowen & Co. report predicts prescription pain drug sales will reach $8.4 billion by 2017. [Wall Street Journal]

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us

Carmel Lobello is the business editor at TheWeek.com. Previously, she was an editor at DeathandTaxesMag.com.